Top Key Companies for Prenatal Testing and Newborn Screening Service Market: PerkinElmer, Natera, Invitae, Centogene, Illumina, Natus Medical, Sequenom, Cradle Genomics, Hoffmann-La Roche, Quest Diagnostics, Baebies, Ravgen, Eurofins Scientific, BGI Genomics, Shanghai Biotecan Pharmaceuticals Corporation, Annaroad Gene, Guangzhou Darui Biotechnology, Beijing Berry Genomics.
Global Prenatal Testing and Newborn Screening Service Market Size was estimated at USD 5817.3 million in 2022 and is projected to reach USD 8922.87 million by 2028, exhibiting a CAGR of 7.39% during the forecast period.
Global Prenatal Testing and Newborn Screening Service Market Overview And Scope:
The Global Prenatal Testing and Newborn Screening Service Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Prenatal Testing and Newborn Screening Service utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Prenatal Testing and Newborn Screening Service Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prenatal Testing and Newborn Screening Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Prenatal Testing and Newborn Screening Service market.
Global Prenatal Testing and Newborn Screening Service Market Segmentation
By Type, Prenatal Testing and Newborn Screening Service market has been segmented into:
Intrusive
Non-Invasive
By Application, Prenatal Testing and Newborn Screening Service market has been segmented into:
Hospital
Diagnostic Center
Others
Regional Analysis of Prenatal Testing and Newborn Screening Service Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Prenatal Testing and Newborn Screening Service Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Prenatal Testing and Newborn Screening Service market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Prenatal Testing and Newborn Screening Service market.
Top Key Companies Covered in Prenatal Testing and Newborn Screening Service market are:
PerkinElmer
Natera
Invitae
Centogene
Illumina
Natus Medical
Sequenom
Cradle Genomics
Hoffmann-La Roche
Quest Diagnostics
Baebies
Ravgen
Eurofins Scientific
BGI Genomics
Shanghai Biotecan Pharmaceuticals Corporation
Annaroad Gene
Guangzhou Darui Biotechnology
Beijing Berry Genomics
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Prenatal Testing and Newborn Screening Service Market by Type
5.1 Prenatal Testing and Newborn Screening Service Market Overview Snapshot and Growth Engine
5.2 Prenatal Testing and Newborn Screening Service Market Overview
5.3 Intrusive
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Intrusive: Geographic Segmentation
5.4 Non-Invasive
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Non-Invasive: Geographic Segmentation
Chapter 6: Prenatal Testing and Newborn Screening Service Market by Application
6.1 Prenatal Testing and Newborn Screening Service Market Overview Snapshot and Growth Engine
6.2 Prenatal Testing and Newborn Screening Service Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Diagnostic Center
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostic Center: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Prenatal Testing and Newborn Screening Service Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Prenatal Testing and Newborn Screening Service Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Prenatal Testing and Newborn Screening Service Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PERKINELMER
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 NATERA
7.4 INVITAE
7.5 CENTOGENE
7.6 ILLUMINA
7.7 NATUS MEDICAL
7.8 SEQUENOM
7.9 CRADLE GENOMICS
7.10 HOFFMANN-LA ROCHE
7.11 QUEST DIAGNOSTICS
7.12 BAEBIES
7.13 RAVGEN
7.14 EUROFINS SCIENTIFIC
7.15 BGI GENOMICS
7.16 SHANGHAI BIOTECAN PHARMACEUTICALS CORPORATION
7.17 ANNAROAD GENE
7.18 GUANGZHOU DARUI BIOTECHNOLOGY
7.19 BEIJING BERRY GENOMICS
Chapter 8: Global Prenatal Testing and Newborn Screening Service Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Intrusive
8.2.2 Non-Invasive
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Diagnostic Center
8.3.3 Others
Chapter 9: North America Prenatal Testing and Newborn Screening Service Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Intrusive
9.4.2 Non-Invasive
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Diagnostic Center
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Prenatal Testing and Newborn Screening Service Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Intrusive
10.4.2 Non-Invasive
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Diagnostic Center
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Prenatal Testing and Newborn Screening Service Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Intrusive
11.4.2 Non-Invasive
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Diagnostic Center
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Prenatal Testing and Newborn Screening Service Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Intrusive
12.4.2 Non-Invasive
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Diagnostic Center
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Prenatal Testing and Newborn Screening Service Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Intrusive
13.4.2 Non-Invasive
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Diagnostic Center
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Prenatal Testing and Newborn Screening Service Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Intrusive
14.4.2 Non-Invasive
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital
14.5.2 Diagnostic Center
14.5.3 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Prenatal Testing and Newborn Screening Service Scope:
|
Report Data
|
Prenatal Testing and Newborn Screening Service Market
|
|
Prenatal Testing and Newborn Screening Service Market Size in 2025
|
USD XX million
|
|
Prenatal Testing and Newborn Screening Service CAGR 2025 - 2032
|
XX%
|
|
Prenatal Testing and Newborn Screening Service Base Year
|
2024
|
|
Prenatal Testing and Newborn Screening Service Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
PerkinElmer, Natera, Invitae, Centogene, Illumina, Natus Medical, Sequenom, Cradle Genomics, Hoffmann-La Roche, Quest Diagnostics, Baebies, Ravgen, Eurofins Scientific, BGI Genomics, Shanghai Biotecan Pharmaceuticals Corporation, Annaroad Gene, Guangzhou Darui Biotechnology, Beijing Berry Genomics.
|
|
Key Segments
|
By Type
Intrusive
Non-Invasive
By Applications
Hospital
Diagnostic Center
Others
|
